KRAS G12C oncogene product, illustration - Stockillustratie

Illustration of the KRAS G12C mutant oncogene product (centre) amongst red and white blood cells. Activation of KRAS promotes cell growth and proliferation. Mutations in KRAS lead to cancer, the uncontrolled growth and proliferation of cells. The G12C mutation is found in a third of lung, and half of colorectal and pancreatic cancers